User Reviews for Cemiplimab
Also known as: Libtayo
Cemiplimab has an average rating of 10.0 out of 10 from a total of 2 ratings on Drugs.com. 100% of reviewers reported a positive effect, while 0% reported a negative effect.
|Squamous Cell Carcinoma||2 reviews||5 medications|
|Summary of Cemiplimab reviews||10.0||2 reviews|
Reviews may be edited to correct grammar/spelling, or to remove inappropriate language and content. Reviews that appear to be created by parties with a vested interest are not published.
Libtayo (cemiplimab) for Squamous Cell Carcinoma: “Severe eczema on my legs, arms and back, along with itchy skin, feels like ants crawling all over my body for the first 3-4 weeks”
Libtayo (cemiplimab) for Squamous Cell Carcinoma: “It caused skin problems, fatigue and shortness of breath.”
This information is not intended to endorse any particular medication. While these reviews may be helpful, they are not a substitute for the expertise, knowledge and judgement of healthcare professionals.
More about cemiplimab
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Interactions
- En Español
- Drug class: anti-PD-1 monoclonal antibodies
- Other brands